HopeStage
Back to all studies
CompletedNCT02060084

Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm

Medication studyChinaEating disorders
The study in practice

Understand this study

Listed locations
KunshanSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2014
Recruitment status
Completed
Enrollment listed in the registry
60
Sponsor
Wang Hua
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
China
Age range
Up to 24 Hours
Official registry ID
NCT02060084
Official title
Show the full official title

Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Kunshan

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Wang Hua.

Did this study involve medication?

Yes. The study involved medication, including a control group and a probiotic-supplemented group.

Want to explore more studies?

Explore studies